128 related articles for article (PubMed ID: 8132281)
1. Altered T and B lymphocytes in multitransfused patients of thalassemia major.
Dua D; Choudhury M; Prakash K
Indian Pediatr; 1993 Jul; 30(7):893-6. PubMed ID: 8132281
[TBL] [Abstract][Full Text] [Related]
2. Immunosurveillance of transfusion dependent thalassaemia and hepatitis B vaccination.
Mazumder M; Sengupta B; De M; Lahiri P; Bhattacharya DK
J Assoc Physicians India; 1993 Jun; 41(6):342-4. PubMed ID: 8005968
[TBL] [Abstract][Full Text] [Related]
3. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
Al-Awadhi AM; Alfadhli SM; Al-Khaldi D; Borhama M; Borusly M
Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
Al-Quobaili FA; Abou Asali IE
Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
[TBL] [Abstract][Full Text] [Related]
6. [Immunological pattern of homozygous beta-thalassemia after splenectomy].
Esposito L; Ferrara M; Ponte G
Pediatria (Napoli); 1983; 91(1):39-44. PubMed ID: 6604258
[No Abstract] [Full Text] [Related]
7. Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major.
Pardalos G; Kanakoudi-Tsakalidis F; Malaka-Zafiriu M; Tsantali H; Athanasiou-Metaxa M; Kallinikos G; Papaevangelou G
Clin Exp Immunol; 1987 Apr; 68(1):138-45. PubMed ID: 3498564
[TBL] [Abstract][Full Text] [Related]
8. Premature senescence of T lymphocytes from patients with beta-thalassemia major.
Gharagozloo M; Bagherpour B; Tahanian M; Oreizy F; Amirghofran Z; Sadeghi HM; Hourfar H; Moayedi B
Immunol Lett; 2009 Jan; 122(1):84-8. PubMed ID: 19118576
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
Aggeli C; Antoniades C; Cosma C; Chrysohoou C; Tousoulis D; Ladis V; Karageorga M; Pitsavos C; Stefanadis C
Int J Cardiol; 2005 Oct; 105(1):80-4. PubMed ID: 16207549
[TBL] [Abstract][Full Text] [Related]
10. [The features of immune status of major beta-thalassemia patients during various periods after splenectomy].
Kadymova EA
Georgian Med News; 2009 Sep; (174):39-44. PubMed ID: 19801729
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subsets and specific T-cell immune response in thalassemia.
Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
[TBL] [Abstract][Full Text] [Related]
12. Hemorheological changes in blood transfusion-treated beta thalassemia major patients.
Mangalani M; Lokeshwar MR; Banerjee R; Nageswari K; Puniyani RR
Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):99-102. PubMed ID: 9699030
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte subset reconstitution after HLA-identical placental blood transplantation (PBT) or PBT plus bone marrow transplantation (BMT) in three children with beta-thalassemia major.
Vitucci A; Lucivero G; Locatelli F; Capocasale M; Tannoia N; Pietrapertosa A
Bone Marrow Transplant; 2000 Oct; 26(7):743-7. PubMed ID: 11042655
[TBL] [Abstract][Full Text] [Related]
14. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
[TBL] [Abstract][Full Text] [Related]
15. [Effect of splenectomy on lymphocyte populations in thalassemia major].
Ballart IJ; Díez RA; Estévez ME; Sen L; Goicoa MA; de Miani SA; Peñalver J
Sangre (Barc); 1985; 30(2):137-45. PubMed ID: 4012516
[No Abstract] [Full Text] [Related]
16. Tricuspid regurgitation in patients with beta-thalassemia major.
Wu KH; Chang JS; Su BH; Peng CT
Ann Hematol; 2004 Dec; 83(12):779-83. PubMed ID: 15449031
[TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte subpopulations in thalassemia major.
Guglielmo P; Cunsolo F; Calogero RD; Marra G; Lombardo M; Cacciola E; Sciacca S; Sortino G
Birth Defects Orig Artic Ser; 1987; 23(5A):581-5. PubMed ID: 2961374
[No Abstract] [Full Text] [Related]
18. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
Suvarna J; Ingle H; Deshmukh CT
Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
[TBL] [Abstract][Full Text] [Related]
19. Common queries in thalassemia care.
Panigrahi I; Marwaha RK
Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant system activity in splenectomized versus non-splenectomized Iranian patients with beta-thalassemia major.
Rashidi A; Alavi S; Arzanian MT; Ahmadinejad M
Pediatr Hematol Oncol; 2007 Dec; 24(8):645-7. PubMed ID: 18092257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
